Correlation Between Akros Monthly and Bionik Laboratories

Can any of the company-specific risk be diversified away by investing in both Akros Monthly and Bionik Laboratories at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akros Monthly and Bionik Laboratories into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Akros Monthly Payout and Bionik Laboratories Corp, you can compare the effects of market volatilities on Akros Monthly and Bionik Laboratories and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akros Monthly with a short position of Bionik Laboratories. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akros Monthly and Bionik Laboratories.

Diversification Opportunities for Akros Monthly and Bionik Laboratories

-0.63

Correlation Coefficient

Akros Monthly  Bionik Laboratories

Excellent diversification

The 3 months correlation between Akros and Bionik is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Akros Monthly Payout and Bionik Laboratories Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bionik Laboratories Corp and Akros Monthly is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akros Monthly Payout are associated (or correlated) with Bionik Laboratories. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bionik Laboratories Corp has no effect on the direction of Akros Monthly i.e., Akros Monthly and Bionik Laboratories go up and down completely randomly.

Pair Corralation between Akros Monthly and Bionik Laboratories

Given the investment horizon of 90 days Akros Monthly Payout is expected to generate 0.05 times more return on investment than Bionik Laboratories. However, Akros Monthly Payout is 21.63 times less risky than Bionik Laboratories. It trades about 0.16 of its potential returns per unit of risk. Bionik Laboratories Corp is currently generating about -0.12 per unit of risk. If you would invest  2,451  in Akros Monthly Payout on September 2, 2024 and sell it today you would earn a total of  151.00  from holding Akros Monthly Payout or generate 6.16% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Akros Monthly Payout  vs.  Bionik Laboratories Corp

Akros Monthly Payout

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Akros Monthly Payout are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Akros Monthly is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Bionik Laboratories Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Bionik Laboratories Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's forward-looking signals remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pair Trading with Akros Monthly and Bionik Laboratories

The main advantage of trading using opposite Akros Monthly and Bionik Laboratories positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akros Monthly position performs unexpectedly, Bionik Laboratories can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionik Laboratories will offset losses from the drop in Bionik Laboratories' long position.

The idea behind Akros Monthly Payout and Bionik Laboratories Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.